The SAMRC’s research, innovation and industry partnerships have seen the organisation feature on various media platforms - sharing new knowledge, up-to-date developments and insights on the SAMRC, South African health systems and factors impacting the health of the nation.

Public Relations
Tel: +27 21 9380407

Corporate & Marketing Communications
Tel: +27 21 938 0274

Latest Press Releases

Cape Town | HVTN 702/Uhambo, one of the three HIV vaccine efficacy studies, underway in South Africa has been stopped early. This decision comes after an independent data and safety monitoring board (DSMB) found during an interim review that the regimen was not effective in preventing HIV. Uhambo was the world’s first HIV vaccine efficacy study conducted in South Africa since 2009.